154 related articles for article (PubMed ID: 22570553)
1. The changing landscape of opioid prescribing: long-acting and extended-release opioid class-wide Risk Evaluation and Mitigation Strategy.
Gudin JA
Ther Clin Risk Manag; 2012; 8():209-17. PubMed ID: 22570553
[TBL] [Abstract][Full Text] [Related]
2. Risk Evaluation and Mitigation Strategies (REMS) for extended-release and long-acting opioid analgesics: considerations for palliative care practice.
Gudin J
J Pain Palliat Care Pharmacother; 2012 Jun; 26(2):136-43. PubMed ID: 22764852
[TBL] [Abstract][Full Text] [Related]
3. Primary care physician opinion survey on FDA opioid risk evaluation and mitigation strategies.
Slevin KA; Ashburn MA
J Opioid Manag; 2011; 7(2):109-15. PubMed ID: 21561034
[TBL] [Abstract][Full Text] [Related]
4. Evolution of opioid risk management and review of the classwide REMS for extended-release/long-acting opioids.
Stanos S
Phys Sportsmed; 2012 Nov; 40(4):12-20. PubMed ID: 23306411
[TBL] [Abstract][Full Text] [Related]
5. ER/LA Opioid Analgesics REMS: Overview of Ongoing Assessments of Its Progress and Its Impact on Health Outcomes.
Cepeda MS; Coplan PM; Kopper NW; Maziere JY; Wedin GP; Wallace LE
Pain Med; 2017 Jan; 18(1):78-85. PubMed ID: 27373304
[TBL] [Abstract][Full Text] [Related]
6. Class-wide REMS for extended-release and long-acting opioids: potential impact on pharmacies.
Matthews ML
J Am Pharm Assoc (2003); 2013; 53(1):e1-7. PubMed ID: 23636166
[TBL] [Abstract][Full Text] [Related]
7. US Food and Drug Administration's Risk Evaluation and Mitigation Strategy for extended-release and long-acting opioids: pros and cons, and a European perspective.
Mercadante S; Craig D; Giarratano A
Drugs; 2012 Dec; 72(18):2327-32. PubMed ID: 23116252
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the Extended-Release/Long-Acting Opioid Prescribing Risk Evaluation and Mitigation Strategy Program by the US Food and Drug Administration: A Review.
Heyward J; Olson L; Sharfstein JM; Stuart EA; Lurie P; Alexander GC
JAMA Intern Med; 2020 Feb; 180(2):301-309. PubMed ID: 31886822
[TBL] [Abstract][Full Text] [Related]
9. Changes in misuse and abuse of prescription opioids following implementation of Extended-Release and Long-Acting Opioid Analgesic Risk Evaluation and Mitigation Strategy.
Bucher Bartelson B; Le Lait MC; Green JL; Cepeda MS; Coplan PM; Maziere JY; Wedin GP; Dart RC
Pharmacoepidemiol Drug Saf; 2017 Sep; 26(9):1061-1070. PubMed ID: 28758289
[TBL] [Abstract][Full Text] [Related]
10. Increase your Confidence in Opioid Prescribing: Marketing Messages in Continuing Medical Education Activities on ER/LA Opioids.
Goodwin B; Lim HD; Butler J; Paglia D; Dempsey MT; O Connor B; Fugh-Berman A
Pain Physician; 2021 Aug; 24(5):E529-E538. PubMed ID: 34323440
[TBL] [Abstract][Full Text] [Related]
11. ER/LA opioid REMS and accredited education: Survey results provide insight into clinical roles, educational needs, and learner preferences.
Kear C; McKeithen T; Robertson S
Subst Abus; 2017; 38(2):145-149. PubMed ID: 28418777
[TBL] [Abstract][Full Text] [Related]
12. Primary care physician attitudes and perceptions of the impact of FDA-proposed REMS policy on prescription of extended-release and long-acting opioids.
Salinas GD; Robinson CO; Abdolrasulnia M
J Pain Res; 2012; 5():363-9. PubMed ID: 23091393
[TBL] [Abstract][Full Text] [Related]
13. Assessment of the FDA Risk Evaluation and Mitigation Strategy for Transmucosal Immediate-Release Fentanyl Products.
Rollman JE; Heyward J; Olson L; Lurie P; Sharfstein J; Alexander GC
JAMA; 2019 Feb; 321(7):676-685. PubMed ID: 30778596
[TBL] [Abstract][Full Text] [Related]
14. SCOPE of Pain: An Evaluation of an Opioid Risk Evaluation and Mitigation Strategy Continuing Education Program.
Alford DP; Zisblatt L; Ng P; Hayes SM; Peloquin S; Hardesty I; White JL
Pain Med; 2016 Jan; 17(1):52-63. PubMed ID: 26304703
[TBL] [Abstract][Full Text] [Related]
15. Extended-release/long-acting opioid REMS may fill the need for prescribers' appropriate use education.
Nicholson SC; Evanyo K; Salinas GD; Roepke N; Burton BS; Susalka D
J Opioid Manag; 2012; 8(4):212-6. PubMed ID: 22941848
[TBL] [Abstract][Full Text] [Related]
16. Assessing the impact of the extended-release/long-acting opioid an-algesics risk evaluation and mitigation strategies on opioid prescrip-tion volume.
Divino V; Cepeda MS; Coplan P; Maziere JY; Yuan Y; Wade RL
J Opioid Manag; 2017; 13(3):157-168. PubMed ID: 28829517
[TBL] [Abstract][Full Text] [Related]
17. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
[TBL] [Abstract][Full Text] [Related]
18. Issues and critiques of the forthcoming risk evaluation and mitigation strategy (REMS) for opioids in pain management.
Peppin JF; Coleman JJ; Kirsh KL
Issues Law Med; 2011; 27(2):91-119. PubMed ID: 22372206
[TBL] [Abstract][Full Text] [Related]
19. Responsible, Safe, and Effective Prescription of Opioids for Chronic Non-Cancer Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines.
Manchikanti L; Kaye AM; Knezevic NN; McAnally H; Slavin K; Trescot AM; Blank S; Pampati V; Abdi S; Grider JS; Kaye AD; Manchikanti KN; Cordner H; Gharibo CG; Harned ME; Albers SL; Atluri S; Aydin SM; Bakshi S; Barkin RL; Benyamin RM; Boswell MV; Buenaventura RM; Calodney AK; Cedeno DL; Datta S; Deer TR; Fellows B; Galan V; Grami V; Hansen H; Helm Ii S; Justiz R; Koyyalagunta D; Malla Y; Navani A; Nouri KH; Pasupuleti R; Sehgal N; Silverman SM; Simopoulos TT; Singh V; Solanki DR; Staats PS; Vallejo R; Wargo BW; Watanabe A; Hirsch JA
Pain Physician; 2017 Feb; 20(2S):S3-S92. PubMed ID: 28226332
[TBL] [Abstract][Full Text] [Related]
20. Candidate metrics for evaluating the impact of prescriber education on the safe use of extended-release/long-acting (ER/LA) opioid analgesics.
Willy ME; Graham DJ; Racoosin JA; Gill R; Kropp GF; Young J; Yang J; Choi J; MaCurdy TE; Worrall C; Kelman JA
Pain Med; 2014 Sep; 15(9):1558-68. PubMed ID: 24828968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]